SEC Form 3: New insider Symetryx Corp claimed ownership of 618,925 shares
$NBSE
Biotechnology: Pharmaceutical Preparations
Health Care
| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 08/23/2023 |
3. Issuer Name and Ticker or Trading Symbol
NeuBase Therapeutics, Inc. [ NBSE ] |
|||||||||||||
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Common Stock, Par Value $0.0001 per Share | 428,444 | D | |
| Common Stock, Par Value $0.0001 per Share | 105,708 | D | |
| Common Stock, Par Value $0.0001 per Share | 3,800 | D | |
| Common Stock, Par Value $0.0001 per Share | 36,485 | D | |
| Common Stock, Par Value $0.0001 per Share | 44,488 | D | |
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Explanation of Responses: |
| Remarks: |
| Table I: Row 1 - Shares listed are beneficially owned by Symetryx Corporation Row 2 - Shares listed are beneficially owned by Barry Shiff Registered Retirement Savings Plan Row 3 - Shares listed are beneficially owned by Barry Shiff Tax Free Savings Account Row 4 - Shares listed are beneficially owned by Aleta Shiff Tax Free Savings Account Row 5 - Shares listed are beneficially owned by Aleta Shiff Registered Retirement Savings Plan Address for all beneficial owners is 2828 Bathurst Street, Suite 400, Toronto, Canada M6B-3A7 Sequence of signatures below correspond to the beneficial holders in the above order |
| Barry Shiff | 09/01/2023 | |
| Barry Shiff | 09/01/2023 | |
| Barry Shiff | 09/01/2023 | |
| Aleta Shiff | 09/01/2023 | |
| Aleta Shiff | 09/01/2023 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||